Irbesartan Terapia (Irbesartan)

Irbesartan works by selectively blocking angiotensin II type 1 (AT1) receptors. This prevents angiotensin II from causing vasoconstriction and aldosterone release, leading to vessel relaxation, reduced sodium and water retention, and ultimately lower blood pressure and decreased stress on the kidneys.

The dose of Irbesartan Terapia is individualized by the prescribing clinician based on the patient’s blood pressure, kidney function, and overall health status. The prescriber determines the appropriate strength and dosing schedule, which may be adjusted over time to achieve optimal therapeutic goals.

Irbesartan is generally not recommended during pregnancy because it may affect fetal kidney development and cause other complications. Data on use while breastfeeding are limited; therefore, the drug should be used only if the potential benefit justifies the potential risk to the infant.

To order Irbesartan Terapia, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and import documentation.

Irbesartan belongs to the ARB class, which offers similar blood‑pressure‑lowering effects as ACE inhibitors but with a lower incidence of cough and angioedema. Both classes block the renin‑angiotensin system; however, ARBs directly antagonize AT1 receptors, whereas ACE inhibitors prevent angiotensin‑II formation.

Irbesartan tablets should be stored at temperatures below 25 °C, in the original container, protected from moisture, heat and direct sunlight. Keep the product out of reach of children and do not use if the packaging is damaged or the tablets appear discoloured.

Irbesartan is taken orally, usually as a whole tablet with or without food. Patients should swallow the tablet whole with a glass of water and follow the dosing schedule prescribed by their healthcare professional.

Serious risks include angioedema (swelling of the face, lips, tongue or throat), severe hypotension, acute renal failure, and significant elevations in liver enzymes. Patients should seek immediate medical attention if they experience swelling, sudden dizziness, reduced urine output, or signs of liver injury.

Irbesartan should not be used by individuals with known hypersensitivity to the drug or any ARB, patients with severe liver impairment, or women who are pregnant or planning pregnancy. Caution is also advised in patients with advanced kidney disease or those taking potassium‑raising agents.